Guest guest Posted May 31, 2006 Report Share Posted May 31, 2006 How interesting! Could someone how has a better sense of the general state of CFIDS research that I do give me an idea of whether this is something truly new? Thanks! Trina Al Melillo <melillo3@...> wrote: --- [CO-CURE] NOTICE: Potential Animal (Zoonotic) Virus Identified in Patients with Chronic Fatigue Syndrome, Multiple Sclerosis and Epilepsy Date: Wed, 31 May 2006 11:06:47 -0700 From: O'Toole <m_otoole2@...> Reply- mods@... CO-CURE@... U.S. Newswire Potential Animal (Zoonotic) Virus Identified in Patients with Chronic Fatigue Syndrome, Multiple Sclerosis and Epilepsy 5/31/2006 12:00:00 PM National Desk Contact: Gail Kansky of the National CFIDS Foundation, 781-449-3535 or gailronda@... NEEDHAM, Mass., May 31 /U.S. Newswire/ -- Recent independent scientific research funded by the National CFIDS Foundation, Inc. (NCF) of Needham, MA provided preliminary confirmation of a new virus identified in patients with Chronic Fatigue Syndrome. The Foundation's medical research dovetails with that completed to date by Cryptic Afflictions, LLC (1), a private company. Dr. J. Robbins, virologist and Chief Executive Officer of Cryptic Afflictions, LLC has discovered a major neuropathogen identified as an RNA virus designated as Cryptovirus. Substantial clinical and molecular evidence indicates that this virus is involved in the development of neurological disorders that include Chronic Fatigue Syndrome (CFS), also known as Myalgic Encephalomyelitis (M.E.) by the World Health Organization, Multiple Sclerosis (M.S.) and Idiopathic Epilepsy of unknown cause. According to the company, " This previously undetected virus appears to be of significant importance to researchers looking for a cure to Multiple Sclerosis and many other neurological illnesses. Antibodies to the newly discovered virus were found in the cerebrospinal fluid and blood of over 90 percent of the patients tested with Multiple Sclerosis. It is believed that this newly discovered virus may prove to be responsible for a host of neurological disorders. Tests are currently being prepared for tissue samples of lesions within the brains of patients with Multiple Sclerosis. This will be the final round of tests before approaching the FDA for approval of the diagnostic tests. " Dr. Robbins' evidence includes the presence of virus-specific antibodies in the serum and cerebrospinal fluid of patients suffering from these disorders, the ability of the virus to cause virtually identical disease in experimentally-infected animals, and nucleotide sequence data that indicates that the virus is pandemic and represents a single virus species much like measles. A recently published medical journal article suggests that Cryptovirus is most similiar to Parainfluenza Virus-5, a rubulavirus in the paramyxovirus family. Another rubulavirus related to Cryptovirus and Parainfluenza Virus-5, that has gained national attention for its large outbreak, is the mumps virus. Rubulavirus infections have been associated with encephalitis, meningitis, orchitis, inflammation of the testicles or ovaries, spontaneous abortion, and deafness. The NCF has conducted its own preliminary research into the potential role of Cryptovirus and Parainfluenza Virus-5 in Chronic Fatigue Syndrome. Professor Alan Cocchetto, Medical Director for the Foundation stated, " Our own funded research first confirmed the lack of a vital protein, known as Stat-1, in the blood of patients with Chronic Fatigue Syndrome. Stat-1 plays an indispensable role in immunity. Without this protein, patients are unable to effectively fight viral and bacterial infections. Thus, the next logical question to be answered was 'Could a virus be causing this Stat-1 depletion?' " Cocchetto continued, " Parainfluenza Virus-5 is a virus that had to be seriously considered as a possible piece of this medical puzzle because it directly targets and destroys the Stat-1 protein. " Gail Kansky, President of the NCF stated, " Once we determined the status of Stat-1 in patient blood samples, we knew that we had to look for possible evidence of Parainfluenza Virus-5 infection. It was during this phase of our own research that we actually learned of Dr. Robbins' discovery of Cryptovirus specific antibody reactivity in patients with CFS. " Dr. Robbins had tested fifty- six serum specimens from patients who had been diagnosed with CFS along with eleven matching cerebrospinal fluid samples obtained from physicians in Brisbane and Southeast Queensland. Dr. Robbins had determined that 96 percent of the blood samples and 91 percent of the spinal fluid samples tested positively for Cryptovirus specific antibodies in these CFS patients. The National CFIDS Foundation's own research began to dovetail with that of Dr. Robbins. Scientists funded by the Foundation performed numerous tests for Parainfluenza Virus-5 that included antibody as well as PCR specific probes. Antibody testing provided some initial hints, however a PCR specific probe picked up the infection in a former patient of S. Bell, M.D. and R. Cheney, Ph.D., M.D., both considered well known specialists in the field of Chronic Fatigue Syndrome. Kansky commented, " Though our funded research continues in diagnostic testing, our findings have served to highlight the important work of Dr. Robbins and the role of Cryptovirus and Parainfluenza Virus-5 infection in CFS. " NCF scientists utilized the NIH Genbank database to find the nucleotide sequence for a specific viral protein of Cryptovirus that matched 100 percent to the porcine (swine) strain of Parainfluenza Virus-5 known as the SER strain. In 1994, scientists at Bayer AG in Germany first isolated the SER strain from swine with Porcine Reproductive and Respiratory Syndrome. " This may represent a zoonotic process since zoonotic viruses are those that can be transmitted between animals and people " stated Cocchetto. Kansky commented, " Here we have what appears to be the same viral strain of Parainfluenza Virus-5 on two continents and in two different populations, swine and humans. Given that the NCF found Parainfluenza Virus-5 in one CFS patient in the United States certainly raises the bar. " The Foundation is currently funding further research. The National Institutes of Health (NIH) has several ongoing grants in the Parainfluenza Virus-5 field. Currently, however, there is only one U.S. scientist specifically funded for research on the SER strain of Parainfluenza Virus-5 by the NIH. --- (1) " Limina Biotechnologies, Inc. is a recently formed subsidiary of Global Medical Technologies, Inc. that was established for the purpose of merging Cryptic Afflictions LLC and Global Medical Technologies, Inc. It is the intent of management to spin off this newly formed corporation once the merger is completed so Limina can raise capital through its own IPO, " according to the company's website, http://www.globalmedicaltech.com. ------ Founded in 1997, the National CFIDS Foundation has grown to become the largest, all-volunteer patient organization of its type in the United States. The Foundation has no paid employees and is funded solely by individual donations for the primary purpose to fund medical research into the cause and treatment and/or cure of Chronic Fatigue Immune Dysfunction Syndrome (CFIDS/CFS). http://www.usnewswire.com/ -0- /© 2006 U.S. Newswire 202-347-2770/ __________________________________________________ Quote Link to comment Share on other sites More sharing options...
Guest guest Posted June 1, 2006 Report Share Posted June 1, 2006 this news release is a little confusing. is the NCF saying that Cryptovirus or Parainfluenza viurs-5 is a potential cause of CFS? these are two similar but distinct viruses, right? any points of clarification... thanks bill > > > > --- [CO-CURE] NOTICE: Potential Animal (Zoonotic) Virus Identified > in Patients with Chronic Fatigue Syndrome, Multiple Sclerosis and Epilepsy > Date: Wed, 31 May 2006 11:06:47 -0700 > From: O'Toole <m_otoole2@...> > Reply- mods@... > CO-CURE@... > > > > U.S. Newswire > > Potential Animal (Zoonotic) Virus Identified in Patients with Chronic Fatigue > Syndrome, Multiple Sclerosis and Epilepsy > > 5/31/2006 12:00:00 PM > > National Desk > > Contact: Gail Kansky of the National CFIDS Foundation, 781-449-3535 or > gailronda@... > > NEEDHAM, Mass., May 31 /U.S. Newswire/ -- Recent independent scientific > research funded by the National CFIDS Foundation, Inc. (NCF) of Needham, MA > provided preliminary confirmation of a new virus identified in patients with > Chronic Fatigue Syndrome. The Foundation's medical research dovetails with that > completed to date by Cryptic Afflictions, LLC (1), a private company. > > Dr. J. Robbins, virologist and Chief Executive Officer of Cryptic > Afflictions, LLC has discovered a major neuropathogen identified as an RNA > virus designated as Cryptovirus. Substantial clinical and molecular evidence > indicates that this virus is involved in the development of neurological > disorders that include Chronic Fatigue Syndrome (CFS), also known as Myalgic > Encephalomyelitis (M.E.) by the World Health Organization, Multiple Sclerosis > (M.S.) and Idiopathic Epilepsy of unknown cause. > > According to the company, " This previously undetected virus appears to be of > significant importance to researchers looking for a cure to Multiple Sclerosis > and many other neurological illnesses. Antibodies to the newly discovered virus > were found in the cerebrospinal fluid and blood of over 90 percent of the > patients tested with Multiple Sclerosis. It is believed that this newly > discovered virus may prove to be responsible for a host of neurological > disorders. Tests are currently being prepared for tissue samples of lesions > within the brains of patients with Multiple Sclerosis. This will be the final > round of tests before approaching the FDA for approval of the diagnostic > tests. " > > Dr. Robbins' evidence includes the presence of virus-specific antibodies in the > serum and cerebrospinal fluid of patients suffering from these disorders, the > ability of the virus to cause virtually identical disease in > experimentally-infected animals, and nucleotide sequence data that indicates > that the virus is pandemic and represents a single virus species much like > measles. > > A recently published medical journal article suggests that Cryptovirus is most > similiar to Parainfluenza Virus-5, a rubulavirus in the paramyxovirus family. > Another rubulavirus related to Cryptovirus and Parainfluenza Virus- 5, that has > gained national attention for its large outbreak, is the mumps virus. > Rubulavirus infections have been associated with encephalitis, meningitis, > orchitis, inflammation of the testicles or ovaries, spontaneous abortion, and > deafness. > > The NCF has conducted its own preliminary research into the potential role of > Cryptovirus and Parainfluenza Virus-5 in Chronic Fatigue Syndrome. Professor > Alan Cocchetto, Medical Director for the Foundation stated, " Our own funded > research first confirmed the lack of a vital protein, known as Stat- 1, in the > blood of patients with Chronic Fatigue Syndrome. Stat-1 plays an indispensable > role in immunity. Without this protein, patients are unable to effectively > fight viral and bacterial infections. Thus, the next logical question to be > answered was 'Could a virus be causing this Stat-1 depletion?' " Cocchetto > continued, " Parainfluenza Virus-5 is a virus that had to be seriously > considered as a possible piece of this medical puzzle because it directly > targets and destroys the Stat-1 protein. " Gail Kansky, President of the NCF > stated, " Once we determined the status of Stat-1 in patient blood samples, we > knew that we had to look for possible evidence of Parainfluenza Virus-5 > infection. It was during this phase of our own research that we actually > learned of Dr. Robbins' discovery of Cryptovirus specific antibody > reactivity in patients with CFS. " Dr. Robbins had tested fifty- six serum > specimens from patients who had been diagnosed with CFS along with eleven > matching cerebrospinal fluid samples obtained from physicians in Brisbane and > Southeast Queensland. Dr. Robbins had determined that 96 percent of the blood > samples and 91 percent of the spinal fluid samples tested positively for > Cryptovirus specific antibodies in these CFS patients. > > The National CFIDS Foundation's own research began to dovetail with that of Dr. > Robbins. Scientists funded by the Foundation performed numerous tests for > Parainfluenza Virus-5 that included antibody as well as PCR specific probes. > Antibody testing provided some initial hints, however a PCR specific probe > picked up the infection in a former patient of S. Bell, M.D. and R. > Cheney, Ph.D., M.D., both considered well known specialists in the field of > Chronic Fatigue Syndrome. Kansky commented, " Though our funded research > continues in diagnostic testing, our findings have served to highlight the > important work of > > Dr. Robbins and the role of Cryptovirus and Parainfluenza Virus-5 infection in > CFS. " > > NCF scientists utilized the NIH Genbank database to find the nucleotide > sequence for a specific viral protein of Cryptovirus that matched 100 percent > to the porcine (swine) strain of Parainfluenza Virus-5 known as the SER strain. > In 1994, scientists at Bayer AG in Germany first isolated the SER strain from > swine with Porcine Reproductive and Respiratory Syndrome. " This may represent a > zoonotic process since zoonotic viruses are those that can be transmitted > between animals and people " stated Cocchetto. Kansky commented, " Here we have > what appears to be the same viral strain of Parainfluenza Virus-5 on two > continents and in two different populations, swine and humans. Given that the > NCF found Parainfluenza Virus-5 in one CFS patient in the United States > certainly raises the bar. " The Foundation is currently funding further > research. > > The National Institutes of Health (NIH) has several ongoing grants in the > Parainfluenza Virus-5 field. Currently, however, there is only one U.S. > scientist specifically funded for research on the SER strain of Parainfluenza > Virus-5 by the NIH. > > --- > > (1) " Limina Biotechnologies, Inc. is a recently formed subsidiary of Global > Medical Technologies, Inc. that was established for the purpose of merging > Cryptic Afflictions LLC and Global Medical Technologies, Inc. It is the intent > of management to spin off this newly formed corporation once the merger is > completed so Limina can raise capital through its own IPO, " according to the > company's website, http://www.globalmedicaltech.com. > > ------ > > Founded in 1997, the National CFIDS Foundation has grown to become the largest, > all-volunteer patient organization of its type in the United States. The > Foundation has no paid employees and is funded solely by individual donations > for the primary purpose to fund medical research into the cause and treatment > and/or cure of Chronic Fatigue Immune Dysfunction Syndrome (CFIDS/CFS). > > http://www.usnewswire.com/ > > -0- > > /© 2006 U.S. Newswire 202-347-2770/ > > > __________________________________________________ > Quote Link to comment Share on other sites More sharing options...
Guest guest Posted June 1, 2006 Report Share Posted June 1, 2006 I find this research really interesting and encouraging, esp. with the recent news of gancycglovir (sp????) or whatever that drug was that caused remission in a small but significant number of ME Patients in England. I've always speculated that something else got transmitted in some tickbites and it wasn't just genetics because my first tickbite was at age 21 I'm pretty sure, and though I had problems, nothing like the second tickbite, as I've often said. I've always wondered if there were unknown viruses transmitted too. One doesn't really know what the synergism is or if getting rid of, say, lyme, will then allow one to get a virus back in latency, or whether the virus initially did the damage. Once you're in a state of ill health they're all problems, bacteria, fungi and viruses. Nice news. > > > --- [CO-CURE] NOTICE: Potential Animal (Zoonotic) Virus Identified > in Patients with Chronic Fatigue Syndrome, Multiple Sclerosis and Epilepsy > Date: Wed, 31 May 2006 11:06:47 -0700 > From: O'Toole <m_otoole2@...> > Reply- mods@... > CO-CURE@... > > > > U.S. Newswire > > Potential Animal (Zoonotic) Virus Identified in Patients with Chronic Fatigue > Syndrome, Multiple Sclerosis and Epilepsy > > 5/31/2006 12:00:00 PM > > National Desk > > Contact: Gail Kansky of the National CFIDS Foundation, 781-449-3535 or > gailronda@... > > NEEDHAM, Mass., May 31 /U.S. Newswire/ -- Recent independent scientific > research funded by the National CFIDS Foundation, Inc. (NCF) of Needham, MA > provided preliminary confirmation of a new virus identified in patients with > Chronic Fatigue Syndrome. The Foundation's medical research dovetails with that > completed to date by Cryptic Afflictions, LLC (1), a private company. > > Dr. J. Robbins, virologist and Chief Executive Officer of Cryptic > Afflictions, LLC has discovered a major neuropathogen identified as an RNA > virus designated as Cryptovirus. Substantial clinical and molecular evidence > indicates that this virus is involved in the development of neurological > disorders that include Chronic Fatigue Syndrome (CFS), also known as Myalgic > Encephalomyelitis (M.E.) by the World Health Organization, Multiple Sclerosis > (M.S.) and Idiopathic Epilepsy of unknown cause. > > According to the company, " This previously undetected virus appears to be of > significant importance to researchers looking for a cure to Multiple Sclerosis > and many other neurological illnesses. Antibodies to the newly discovered virus > were found in the cerebrospinal fluid and blood of over 90 percent of the > patients tested with Multiple Sclerosis. It is believed that this newly > discovered virus may prove to be responsible for a host of neurological > disorders. Tests are currently being prepared for tissue samples of lesions > within the brains of patients with Multiple Sclerosis. This will be the final > round of tests before approaching the FDA for approval of the diagnostic > tests. " > > Dr. Robbins' evidence includes the presence of virus-specific antibodies in the > serum and cerebrospinal fluid of patients suffering from these disorders, the > ability of the virus to cause virtually identical disease in > experimentally-infected animals, and nucleotide sequence data that indicates > that the virus is pandemic and represents a single virus species much like > measles. > > A recently published medical journal article suggests that Cryptovirus is most > similiar to Parainfluenza Virus-5, a rubulavirus in the paramyxovirus family. > Another rubulavirus related to Cryptovirus and Parainfluenza Virus-5, that has > gained national attention for its large outbreak, is the mumps virus. > Rubulavirus infections have been associated with encephalitis, meningitis, > orchitis, inflammation of the testicles or ovaries, spontaneous abortion, and > deafness. > > The NCF has conducted its own preliminary research into the potential role of > Cryptovirus and Parainfluenza Virus-5 in Chronic Fatigue Syndrome. Professor > Alan Cocchetto, Medical Director for the Foundation stated, " Our own funded > research first confirmed the lack of a vital protein, known as Stat-1, in the > blood of patients with Chronic Fatigue Syndrome. Stat-1 plays an indispensable > role in immunity. Without this protein, patients are unable to effectively > fight viral and bacterial infections. Thus, the next logical question to be > answered was 'Could a virus be causing this Stat-1 depletion?' " Cocchetto > continued, " Parainfluenza Virus-5 is a virus that had to be seriously > considered as a possible piece of this medical puzzle because it directly > targets and destroys the Stat-1 protein. " Gail Kansky, President of the NCF > stated, " Once we determined the status of Stat-1 in patient blood samples, we > knew that we had to look for possible evidence of Parainfluenza Virus-5 > infection. It was during this phase of our own research that we actually > learned of Dr. Robbins' discovery of Cryptovirus specific antibody > reactivity in patients with CFS. " Dr. Robbins had tested fifty- six serum > specimens from patients who had been diagnosed with CFS along with eleven > matching cerebrospinal fluid samples obtained from physicians in Brisbane and > Southeast Queensland. Dr. Robbins had determined that 96 percent of the blood > samples and 91 percent of the spinal fluid samples tested positively for > Cryptovirus specific antibodies in these CFS patients. > > The National CFIDS Foundation's own research began to dovetail with that of Dr. > Robbins. Scientists funded by the Foundation performed numerous tests for > Parainfluenza Virus-5 that included antibody as well as PCR specific probes. > Antibody testing provided some initial hints, however a PCR specific probe > picked up the infection in a former patient of S. Bell, M.D. and R. > Cheney, Ph.D., M.D., both considered well known specialists in the field of > Chronic Fatigue Syndrome. Kansky commented, " Though our funded research > continues in diagnostic testing, our findings have served to highlight the > important work of > > Dr. Robbins and the role of Cryptovirus and Parainfluenza Virus-5 infection in > CFS. " > > NCF scientists utilized the NIH Genbank database to find the nucleotide > sequence for a specific viral protein of Cryptovirus that matched 100 percent > to the porcine (swine) strain of Parainfluenza Virus-5 known as the SER strain. > In 1994, scientists at Bayer AG in Germany first isolated the SER strain from > swine with Porcine Reproductive and Respiratory Syndrome. " This may represent a > zoonotic process since zoonotic viruses are those that can be transmitted > between animals and people " stated Cocchetto. Kansky commented, " Here we have > what appears to be the same viral strain of Parainfluenza Virus-5 on two > continents and in two different populations, swine and humans. Given that the > NCF found Parainfluenza Virus-5 in one CFS patient in the United States > certainly raises the bar. " The Foundation is currently funding further > research. > > The National Institutes of Health (NIH) has several ongoing grants in the > Parainfluenza Virus-5 field. Currently, however, there is only one U.S. > scientist specifically funded for research on the SER strain of Parainfluenza > Virus-5 by the NIH. > > --- > > (1) " Limina Biotechnologies, Inc. is a recently formed subsidiary of Global > Medical Technologies, Inc. that was established for the purpose of merging > Cryptic Afflictions LLC and Global Medical Technologies, Inc. It is the intent > of management to spin off this newly formed corporation once the merger is > completed so Limina can raise capital through its own IPO, " according to the > company's website, http://www.globalmedicaltech.com. > > ------ > > Founded in 1997, the National CFIDS Foundation has grown to become the largest, > all-volunteer patient organization of its type in the United States. The > Foundation has no paid employees and is funded solely by individual donations > for the primary purpose to fund medical research into the cause and treatment > and/or cure of Chronic Fatigue Immune Dysfunction Syndrome (CFIDS/CFS). > > http://www.usnewswire.com/ > > -0- > > /© 2006 U.S. Newswire 202-347-2770/ > > > __________________________________________________ > Quote Link to comment Share on other sites More sharing options...
Guest guest Posted June 1, 2006 Report Share Posted June 1, 2006 Hi Bill, I was confused about this too, but it's explained in detail here: http://ncf-net.org/library/PIV5HostChallenge-0606.htm > > this news release is a little confusing. > > is the NCF saying that Cryptovirus or Parainfluenza viurs-5 is a > potential cause of CFS? > > these are two similar but distinct viruses, right? > > any points of clarification... > > thanks > bill > Quote Link to comment Share on other sites More sharing options...
Guest guest Posted June 1, 2006 Report Share Posted June 1, 2006 --- [CO-CURE] NOTICE: Potential Animal (Zoonotic) Virus Identified in Patients with Chronic Fatigue Syndrome, Multiple Sclerosis and Epilepsy Date: Wed, 31 May 2006 11:06:47 -0700 From: O'Toole <m_otoole2@...> Reply- mods@... CO-CURE@... U.S. Newswire Potential Animal (Zoonotic) Virus Identified in Patients with Chronic Fatigue Syndrome, Multiple Sclerosis and Epilepsy 5/31/2006 12:00:00 PM National Desk Contact: Gail Kansky of the National CFIDS Foundation, 781-449-3535 or gailronda@... NEEDHAM, Mass., May 31 /U.S. Newswire/ -- Recent independent scientific research funded by the National CFIDS Foundation, Inc. (NCF) of Needham, MA provided preliminary confirmation of a new virus identified in patients with Chronic Fatigue Syndrome. The Foundation's medical research dovetails with that completed to date by Cryptic Afflictions, LLC (1), a private company. Dr. J. Robbins, virologist and Chief Executive Officer of Cryptic Afflictions, LLC has discovered a major neuropathogen identified as an RNA virus designated as Cryptovirus. Substantial clinical and molecular evidence indicates that this virus is involved in the development of neurological disorders that include Chronic Fatigue Syndrome (CFS), also known as Myalgic Encephalomyelitis (M.E.) by the World Health Organization, Multiple Sclerosis (M.S.) and Idiopathic Epilepsy of unknown cause. According to the company, " This previously undetected virus appears to be of significant importance to researchers looking for a cure to Multiple Sclerosis and many other neurological illnesses. Antibodies to the newly discovered virus were found in the cerebrospinal fluid and blood of over 90 percent of the patients tested with Multiple Sclerosis. It is believed that this newly discovered virus may prove to be responsible for a host of neurological disorders. Tests are currently being prepared for tissue samples of lesions within the brains of patients with Multiple Sclerosis. This will be the final round of tests before approaching the FDA for approval of the diagnostic tests. " Dr. Robbins' evidence includes the presence of virus-specific antibodies in the serum and cerebrospinal fluid of patients suffering from these disorders, the ability of the virus to cause virtually identical disease in experimentally-infected animals, and nucleotide sequence data that indicates that the virus is pandemic and represents a single virus species much like measles. A recently published medical journal article suggests that Cryptovirus is most similiar to Parainfluenza Virus-5, a rubulavirus in the paramyxovirus family. Another rubulavirus related to Cryptovirus and Parainfluenza Virus-5, that has gained national attention for its large outbreak, is the mumps virus. Rubulavirus infections have been associated with encephalitis, meningitis, orchitis, inflammation of the testicles or ovaries, spontaneous abortion, and deafness. The NCF has conducted its own preliminary research into the potential role of Cryptovirus and Parainfluenza Virus-5 in Chronic Fatigue Syndrome. Professor Alan Cocchetto, Medical Director for the Foundation stated, " Our own funded research first confirmed the lack of a vital protein, known as Stat-1, in the blood of patients with Chronic Fatigue Syndrome. Stat-1 plays an indispensable role in immunity. Without this protein, patients are unable to effectively fight viral and bacterial infections. Thus, the next logical question to be answered was 'Could a virus be causing this Stat-1 depletion?' " Cocchetto continued, " Parainfluenza Virus-5 is a virus that had to be seriously considered as a possible piece of this medical puzzle because it directly targets and destroys the Stat-1 protein. " Gail Kansky, President of the NCF stated, " Once we determined the status of Stat-1 in patient blood samples, we knew that we had to look for possible evidence of Parainfluenza Virus-5 infection. It was during this phase of our own research that we actually learned of Dr. Robbins' discovery of Cryptovirus specific antibody reactivity in patients with CFS. " Dr. Robbins had tested fifty- six serum specimens from patients who had been diagnosed with CFS along with eleven matching cerebrospinal fluid samples obtained from physicians in Brisbane and Southeast Queensland. Dr. Robbins had determined that 96 percent of the blood samples and 91 percent of the spinal fluid samples tested positively for Cryptovirus specific antibodies in these CFS patients. The National CFIDS Foundation's own research began to dovetail with that of Dr. Robbins. Scientists funded by the Foundation performed numerous tests for Parainfluenza Virus-5 that included antibody as well as PCR specific probes. Antibody testing provided some initial hints, however a PCR specific probe picked up the infection in a former patient of S. Bell, M.D. and R. Cheney, Ph.D., M.D., both considered well known specialists in the field of Chronic Fatigue Syndrome. Kansky commented, " Though our funded research continues in diagnostic testing, our findings have served to highlight the important work of Dr. Robbins and the role of Cryptovirus and Parainfluenza Virus-5 infection in CFS. " NCF scientists utilized the NIH Genbank database to find the nucleotide sequence for a specific viral protein of Cryptovirus that matched 100 percent to the porcine (swine) strain of Parainfluenza Virus-5 known as the SER strain. In 1994, scientists at Bayer AG in Germany first isolated the SER strain from swine with Porcine Reproductive and Respiratory Syndrome. " This may represent a zoonotic process since zoonotic viruses are those that can be transmitted between animals and people " stated Cocchetto. Kansky commented, " Here we have what appears to be the same viral strain of Parainfluenza Virus-5 on two continents and in two different populations, swine and humans. Given that the NCF found Parainfluenza Virus-5 in one CFS patient in the United States certainly raises the bar. " The Foundation is currently funding further research. The National Institutes of Health (NIH) has several ongoing grants in the Parainfluenza Virus-5 field. Currently, however, there is only one U.S. scientist specifically funded for research on the SER strain of Parainfluenza Virus-5 by the NIH. --- (1) " Limina Biotechnologies, Inc. is a recently formed subsidiary of Global Medical Technologies, Inc. that was established for the purpose of merging Cryptic Afflictions LLC and Global Medical Technologies, Inc. It is the intent of management to spin off this newly formed corporation once the merger is completed so Limina can raise capital through its own IPO, " according to the company's website, http://www.globalmedicaltech.com. ------ Founded in 1997, the National CFIDS Foundation has grown to become the largest, all-volunteer patient organization of its type in the United States. The Foundation has no paid employees and is funded solely by individual donations for the primary purpose to fund medical research into the cause and treatment and/or cure of Chronic Fatigue Immune Dysfunction Syndrome (CFIDS/CFS). http://www.usnewswire.com/ -0- /© 2006 U.S. Newswire 202-347-2770/ __________________________________________________ Quote Link to comment Share on other sites More sharing options...
Guest guest Posted June 2, 2006 Report Share Posted June 2, 2006 so this is what Gail's been hinting at forever. pennyAl Melillo <melillo3@...> wrote: --- [CO-CURE] NOTICE: Potential Animal (Zoonotic) Virus Identified in Patients with Chronic Fatigue Syndrome, Multiple Sclerosis and EpilepsyDate: Wed, 31 May 2006 11:06:47 -0700From: O'Toole <m_otoole2@...>Reply- mods@...To: CO-CURE@...U.S. NewswirePotential Animal (Zoonotic) Virus Identified in Patients with Chronic FatigueSyndrome, Multiple Sclerosis and Epilepsy5/31/2006 12:00:00 PMNational DeskContact: Gail Kansky of the National CFIDS Foundation, 781-449-3535 orgailronda@...NEEDHAM, Mass., May 31 /U.S. Newswire/ -- Recent independent scientificresearch funded by the National CFIDS Foundation, Inc. (NCF) of Needham, MAprovided preliminary confirmation of a new virus identified in patients withChronic Fatigue Syndrome. The Foundation's medical research dovetails with thatcompleted to date by Cryptic Afflictions, LLC (1), a private company.Dr. J. Robbins, virologist and Chief Executive Officer of CrypticAfflictions, LLC has discovered a major neuropathogen identified as an RNAvirus designated as Cryptovirus. Substantial clinical and molecular evidenceindicates that this virus is involved in the development of neurologicaldisorders that include Chronic Fatigue Syndrome (CFS), also known as MyalgicEncephalomyelitis (M.E.) by the World Health Organization, Multiple Sclerosis(M.S.) and Idiopathic Epilepsy of unknown cause.According to the company, "This previously undetected virus appears to be ofsignificant importance to researchers looking for a cure to Multiple Sclerosisand many other neurological illnesses. Antibodies to the newly discovered viruswere found in the cerebrospinal fluid and blood of over 90 percent of thepatients tested with Multiple Sclerosis. It is believed that this newlydiscovered virus may prove to be responsible for a host of neurologicaldisorders. Tests are currently being prepared for tissue samples of lesionswithin the brains of patients with Multiple Sclerosis. This will be the finalround of tests before approaching the FDA for approval of the diagnostictests."Dr. Robbins' evidence includes the presence of virus-specific antibodies in theserum and cerebrospinal fluid of patients suffering from these disorders, theability of the virus to cause virtually identical disease inexperimentally-infected animals, and nucleotide sequence data that indicatesthat the virus is pandemic and represents a single virus species much likemeasles.A recently published medical journal article suggests that Cryptovirus is mostsimiliar to Parainfluenza Virus-5, a rubulavirus in the paramyxovirus family.Another rubulavirus related to Cryptovirus and Parainfluenza Virus-5, that hasgained national attention for its large outbreak, is the mumps virus.Rubulavirus infections have been associated with encephalitis, meningitis,orchitis, inflammation of the testicles or ovaries, spontaneous abortion, anddeafness.The NCF has conducted its own preliminary research into the potential role ofCryptovirus and Parainfluenza Virus-5 in Chronic Fatigue Syndrome. ProfessorAlan Cocchetto, Medical Director for the Foundation stated, "Our own fundedresearch first confirmed the lack of a vital protein, known as Stat-1, in theblood of patients with Chronic Fatigue Syndrome. Stat-1 plays an indispensablerole in immunity. Without this protein, patients are unable to effectivelyfight viral and bacterial infections. Thus, the next logical question to beanswered was 'Could a virus be causing this Stat-1 depletion?' " Cocchettocontinued, "Parainfluenza Virus-5 is a virus that had to be seriouslyconsidered as a possible piece of this medical puzzle because it directlytargets and destroys the Stat-1 protein." Gail Kansky, President of the NCFstated, "Once we determined the status of Stat-1 in patient blood samples, weknew that we had to look for possible evidence of Parainfluenza Virus-5infection. It was during this phase of our own research that we actuallylearned of Dr. Robbins' discovery of Cryptovirus specific antibodyreactivity in patients with CFS." Dr. Robbins had tested fifty- six serumspecimens from patients who had been diagnosed with CFS along with elevenmatching cerebrospinal fluid samples obtained from physicians in Brisbane andSoutheast Queensland. Dr. Robbins had determined that 96 percent of the bloodsamples and 91 percent of the spinal fluid samples tested positively forCryptovirus specific antibodies in these CFS patients.The National CFIDS Foundation's own research began to dovetail with that of Dr.Robbins. Scientists funded by the Foundation performed numerous tests forParainfluenza Virus-5 that included antibody as well as PCR specific probes.Antibody testing provided some initial hints, however a PCR specific probepicked up the infection in a former patient of S. Bell, M.D. and R.Cheney, Ph.D., M.D., both considered well known specialists in the field ofChronic Fatigue Syndrome. Kansky commented, "Though our funded researchcontinues in diagnostic testing, our findings have served to highlight theimportant work ofDr. Robbins and the role of Cryptovirus and Parainfluenza Virus-5 infection inCFS."NCF scientists utilized the NIH Genbank database to find the nucleotidesequence for a specific viral protein of Cryptovirus that matched 100 percentto the porcine (swine) strain of Parainfluenza Virus-5 known as the SER strain.In 1994, scientists at Bayer AG in Germany first isolated the SER strain fromswine with Porcine Reproductive and Respiratory Syndrome. "This may represent azoonotic process since zoonotic viruses are those that can be transmittedbetween animals and people" stated Cocchetto. Kansky commented, "Here we havewhat appears to be the same viral strain of Parainfluenza Virus-5 on twocontinents and in two different populations, swine and humans. Given that theNCF found Parainfluenza Virus-5 in one CFS patient in the United Statescertainly raises the bar." The Foundation is currently funding furtherresearch.The National Institutes of Health (NIH) has several ongoing grants in theParainfluenza Virus-5 field. Currently, however, there is only one U.S.scientist specifically funded for research on the SER strain of ParainfluenzaVirus-5 by the NIH.---(1) "Limina Biotechnologies, Inc. is a recently formed subsidiary of GlobalMedical Technologies, Inc. that was established for the purpose of mergingCryptic Afflictions LLC and Global Medical Technologies, Inc. It is the intentof management to spin off this newly formed corporation once the merger iscompleted so Limina can raise capital through its own IPO," according to thecompany's website, http://www.globalmedicaltech.com.------Founded in 1997, the National CFIDS Foundation has grown to become the largest,all-volunteer patient organization of its type in the United States. TheFoundation has no paid employees and is funded solely by individual donationsfor the primary purpose to fund medical research into the cause and treatmentand/or cure of Chronic Fatigue Immune Dysfunction Syndrome (CFIDS/CFS).http://www.usnewswire.com/-0-/© 2006 U.S. Newswire 202-347-2770/__________________________________________________ Quote Link to comment Share on other sites More sharing options...
Guest guest Posted June 2, 2006 Report Share Posted June 2, 2006 Hi Penny & all, Dr. Vernon at the CDC who did the CFS genetic study thanked me for Emailing her the report. She said she would inform her CFS research staff members. Al > -------- Original Message -------- >>> > U.S. Newswire > > Potential Animal (Zoonotic) Virus Identified in Patients with Chronic Fatigue > Syndrome, Multiple Sclerosis and Epilepsy > > 5/31/2006 12:00:00 PM > > National Desk > > Contact: Gail Kansky of the National CFIDS Foundation, 781-449- 3535 or > gailronda@... > > NEEDHAM, Mass., May 31 /U.S. Newswire/ -- Recent independent scientific > research funded by the National CFIDS Foundation, Inc. (NCF) of Needham, MA > provided preliminary confirmation of a new virus identified in patients with > Chronic Fatigue Syndrome. The Foundation's medical research dovetails with that > completed to date by Cryptic Afflictions, LLC (1), a private company. > > Dr. J. Robbins, virologist and Chief Executive Officer of Cryptic > Afflictions, LLC has discovered a major neuropathogen identified as an RNA > virus designated as Cryptovirus. Substantial clinical and molecular evidence > indicates that this virus is involved in the development of neurological > disorders that include Chronic Fatigue Syndrome (CFS), also known as Myalgic > Encephalomyelitis (M.E.) by the World Health Organization, Multiple Sclerosis > (M.S.) and Idiopathic Epilepsy of unknown cause. > > According to the company, " This previously undetected virus appears to be of > significant importance to researchers looking for a cure to Multiple Sclerosis > and many other neurological illnesses. Antibodies to the newly discovered virus > were found in the cerebrospinal fluid and blood of over 90 percent of the > patients tested with Multiple Sclerosis. It is believed that this newly > discovered virus may prove to be responsible for a host of neurological > disorders. Tests are currently being prepared for tissue samples of lesions > within the brains of patients with Multiple Sclerosis. This will be the final > round of tests before approaching the FDA for approval of the diagnostic > tests. " > > Dr. Robbins' evidence includes the presence of virus-specific antibodies in the > serum and cerebrospinal fluid of patients suffering from these disorders, the > ability of the virus to cause virtually identical disease in > experimentally-infected animals, and nucleotide sequence data that indicates > that the virus is pandemic and represents a single virus species much like > measles. > > A recently published medical journal article suggests that Cryptovirus is most > similiar to Parainfluenza Virus-5, a rubulavirus in the paramyxovirus family. > Another rubulavirus related to Cryptovirus and Parainfluenza Virus- 5, that has > gained national attention for its large outbreak, is the mumps virus. > Rubulavirus infections have been associated with encephalitis, meningitis, > orchitis, inflammation of the testicles or ovaries, spontaneous abortion, and > deafness. > > The NCF has conducted its own preliminary research into the potential role of > Cryptovirus and Parainfluenza Virus-5 in Chronic Fatigue Syndrome. Professor > Alan Cocchetto, Medical Director for the Foundation stated, " Our own funded > research first confirmed the lack of a vital protein, known as Stat-1, in the > blood of patients with Chronic Fatigue Syndrome. Stat-1 plays an indispensable > role in immunity. Without this protein, patients are unable to effectively > fight viral and bacterial infections. Thus, the next logical question to be > answered was 'Could a virus be causing this Stat-1 depletion?' " Cocchetto > continued, " Parainfluenza Virus-5 is a virus that had to be seriously > considered as a possible piece of this medical puzzle because it directly > targets and destroys the Stat-1 protein. " Gail Kansky, President of the NCF > stated, " Once we determined the status of Stat-1 in patient blood samples, we > knew that we had to look for possible evidence of Parainfluenza Virus-5 > infection. It was during this phase of our own research that we actually > learned of Dr. Robbins' discovery of Cryptovirus specific antibody > reactivity in patients with CFS. " Dr. Robbins had tested fifty- six serum > specimens from patients who had been diagnosed with CFS along with eleven > matching cerebrospinal fluid samples obtained from physicians in Brisbane and > Southeast Queensland. Dr. Robbins had determined that 96 percent of the blood > samples and 91 percent of the spinal fluid samples tested positively for > Cryptovirus specific antibodies in these CFS patients. > > The National CFIDS Foundation's own research began to dovetail with that of Dr. > Robbins. Scientists funded by the Foundation performed numerous tests for > Parainfluenza Virus-5 that included antibody as well as PCR specific probes. > Antibody testing provided some initial hints, however a PCR specific probe > picked up the infection in a former patient of S. Bell, M.D. and R. > Cheney, Ph.D., M.D., both considered well known specialists in the field of > Chronic Fatigue Syndrome. Kansky commented, " Though our funded research > continues in diagnostic testing, our findings have served to highlight the > important work of > > Dr. Robbins and the role of Cryptovirus and Parainfluenza Virus-5 infection in > CFS. " > > NCF scientists utilized the NIH Genbank database to find the nucleotide > sequence for a specific viral protein of Cryptovirus that matched 100 percent > to the porcine (swine) strain of Parainfluenza Virus-5 known as the SER strain. > In 1994, scientists at Bayer AG in Germany first isolated the SER strain from > swine with Porcine Reproductive and Respiratory Syndrome. " This may represent a > zoonotic process since zoonotic viruses are those that can be transmitted > between animals and people " stated Cocchetto. Kansky commented, " Here we have > what appears to be the same viral strain of Parainfluenza Virus-5 on two > continents and in two different populations, swine and humans. Given that the > NCF found Parainfluenza Virus-5 in one CFS patient in the United States > certainly raises the bar. " The Foundation is currently funding further > research. > > The National Institutes of Health (NIH) has several ongoing grants in the > Parainfluenza Virus-5 field. Currently, however, there is only one U.S. > scientist specifically funded for research on the SER strain of Parainfluenza > Virus-5 by the NIH. > > --- > > (1) " Limina Biotechnologies, Inc. is a recently formed subsidiary of Global > Medical Technologies, Inc. that was established for the purpose of merging > Cryptic Afflictions LLC and Global Medical Technologies, Inc. It is the intent > of management to spin off this newly formed corporation once the merger is > completed so Limina can raise capital through its own IPO, " according to the > company's website, http://www.globalmedicaltech.com. > > ------ > > Founded in 1997, the National CFIDS Foundation has grown to become the largest, > all-volunteer patient organization of its type in the United States. The > Foundation has no paid employees and is funded solely by individual donations > for the primary purpose to fund medical research into the cause and treatment > and/or cure of Chronic Fatigue Immune Dysfunction Syndrome (CFIDS/CFS). > > http://www.usnewswire.com/ > > -0- > > /© 2006 U.S. Newswire 202-347-2770/ > > > __________________________________________________ > Quote Link to comment Share on other sites More sharing options...
Guest guest Posted June 2, 2006 Report Share Posted June 2, 2006 Al, We need to remind the CDC that they have yet to test those lymph node biopsies from Dr. Bell in the 1980’s. They day they start testing for anything I will pass out in shock. a Hi Penny & all, Dr. Vernon at the CDC who did the CFS genetic study thanked me for Emailing her the report. She said she would inform her CFS research staff members. Al Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.